Related Experiment Video
Updated: Jan 10, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
A novel machine-learning based optimization: identifying new treatment regimens for tuberculosis
Maral Budak1, Pariksheet Nanda1, Denise Kirschner1
1Dept. of Microbiology and Immunology, University of Michigan Medical School 48109-5620, Ann Arbor, MI, United States.
Abstract:
Identifying optimization in a system from any discipline requires identifying ways to either maximize or minimize objectives of interest-or even trade-offs between these choices where goals must be balanced. Traditionally, optimal control theory has been used specifically for applications that are represented by ordinary differential equations. Here, we introduce a new approach to optimization that can be applied not only to ordinary differential-equation based systems, but importantly to other more complex models, such as agent-based model systems. To this end, we create a novel machine learning optimization pipeline that uses a Kriging-based surrogate model to predict objective functions. We use a Pareto optimization algorithm to identify regimens that maximize improvement to the predicted optimal set and then rank these findings. As an example, we apply this to a model system that captures drug treatment of hosts during infection with Mycobacterium tuberculosis. Typically for treatment of tuberculosis, a multiple drug regimen is used where four antibiotics are administered for a lengthy time frame of 6-9 months. We apply our new method to optimize treatment in the face of many choices for drugs, combinations and dosages and link for the first time with rankings to the optimized set of outcomes.
More Related Videos
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Dosage Regimen Designs: Nomograms and Tabulations